
CORD-19:775b90287b44353bee979abb0970a4666022f86d / 732925-733328
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T65732","span":{"begin":0,"end":403},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Of the 6877 skin test records in the database, 534 patients were identified who had at least a moderate SPT to short ragweed (approximately an 8mm wheal or greater), had a diagnosis of allergic rhinitis, were not already on SCIT, had a current email address on file and, based on the prescribing information of the recently approved sublingual ragweed extract tablet, were between the ages of 18 and 65."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T7","span":{"begin":0,"end":403},"obj":"Sentence"}],"text":"Of the 6877 skin test records in the database, 534 patients were identified who had at least a moderate SPT to short ragweed (approximately an 8mm wheal or greater), had a diagnosis of allergic rhinitis, were not already on SCIT, had a current email address on file and, based on the prescribing information of the recently approved sublingual ragweed extract tablet, were between the ages of 18 and 65."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5545","span":{"begin":185,"end":202},"obj":"Disease"},{"id":"T5546","span":{"begin":185,"end":193},"obj":"Disease"},{"id":"T5547","span":{"begin":194,"end":202},"obj":"Disease"},{"id":"T76328","span":{"begin":185,"end":202},"obj":"Disease"},{"id":"T80040","span":{"begin":185,"end":193},"obj":"Disease"},{"id":"T92003","span":{"begin":194,"end":202},"obj":"Disease"}],"attributes":[{"id":"A5545","pred":"mondo_id","subj":"T5545","obj":"http://purl.obolibrary.org/obo/MONDO_0011786"},{"id":"A5546","pred":"mondo_id","subj":"T5546","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A5547","pred":"mondo_id","subj":"T5547","obj":"http://purl.obolibrary.org/obo/MONDO_0003014"},{"id":"A24734","pred":"mondo_id","subj":"T76328","obj":"http://purl.obolibrary.org/obo/MONDO_0011786"},{"id":"A70163","pred":"mondo_id","subj":"T80040","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A16377","pred":"mondo_id","subj":"T92003","obj":"http://purl.obolibrary.org/obo/MONDO_0003014"}],"text":"Of the 6877 skin test records in the database, 534 patients were identified who had at least a moderate SPT to short ragweed (approximately an 8mm wheal or greater), had a diagnosis of allergic rhinitis, were not already on SCIT, had a current email address on file and, based on the prescribing information of the recently approved sublingual ragweed extract tablet, were between the ages of 18 and 65."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T3904","span":{"begin":185,"end":202},"obj":"Phenotype"}],"attributes":[{"id":"A3904","pred":"hp_id","subj":"T3904","obj":"http://purl.obolibrary.org/obo/HP_0003193"}],"text":"Of the 6877 skin test records in the database, 534 patients were identified who had at least a moderate SPT to short ragweed (approximately an 8mm wheal or greater), had a diagnosis of allergic rhinitis, were not already on SCIT, had a current email address on file and, based on the prescribing information of the recently approved sublingual ragweed extract tablet, were between the ages of 18 and 65."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1481","span":{"begin":12,"end":16},"obj":"Body_part"},{"id":"T1482","span":{"begin":333,"end":343},"obj":"Body_part"}],"attributes":[{"id":"A1481","pred":"uberon_id","subj":"T1481","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"id":"A1482","pred":"uberon_id","subj":"T1482","obj":"http://purl.obolibrary.org/obo/UBERON_2001275"}],"text":"Of the 6877 skin test records in the database, 534 patients were identified who had at least a moderate SPT to short ragweed (approximately an 8mm wheal or greater), had a diagnosis of allergic rhinitis, were not already on SCIT, had a current email address on file and, based on the prescribing information of the recently approved sublingual ragweed extract tablet, were between the ages of 18 and 65."}